MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Pulmonology (COPD-Chronic Obstructive Pulmonary Disorder), Emphysema
Innoviva, Inc. (NASDAQ: INVA)
Organization & Developments: Innoviva
Parents
Innoviva, Inc. (NASDAQ: INVA)
Children
*Innoviva is a diversified holding company with a portfolio of royalties and other healthcare assets.
*Innoviva’s royalty portfolio includes respiratory assets partnered with Glaxo Group Limited (“GSK”), including RELVAR®/BREO® ELLIPTA® (fluticasone furoate/ vilanterol, “FF/VI”), ANORO® ELLIPTA® (umeclidinium bromide/ vilanterol, “UMEC/VI”) and TRELEGY® ELLIPTA® (the combination FF/UMEC/VI).
2025: Innoviva: A Riddle Wrapped In A Mystery Inside An Enigma
20r5: US FDA approves Innoviva's oral antibiotic for gonorrhea
Jumps
Finance & Acquisitions: Innoviva
Key People: Innoviva